Innovation Engine Report

Backlog Reconciliation Of Non-GAAP Measures This information reconciles non-GAAP measures with the most directly comparable GAAP measure (dollars in millions, except per share amounts) Backlog (GAAP) AspenTech Backlog excluding AspenTech (non-GAAP) Cash Flow Operating cash flow (GAAP) Capital expenditures Free cash flow (non-GAAP) Cash Flow Operating cash flow (GAAP) Capital expenditures Free cash flow (non-GAAP) Free Cash Flow Conversion Operating cash flow conversion (GAAP) Capital expenditures Amortization of intangibles / restructuring and related costs / AspenTech Micromine purchase price hedge / Acquisition and divestiture fees / interest income on undeployed proceeds / Copeland equity method investment loss Adjusted free cash flow conversion (non-GAAP) References to underlying orders and underlying sales in this presentation exclude the impact of acquisitions, divestitures and currency translation June 30, 2023 $8.2 (1.3) $6.9 Q3 FY22 Q3 FY23 Change $479 (59) $420 $842 (73) $769 76% 7% 83% Nine Months Ended June 30, 2022 Nine Months Ended June 30, 2023 Change $1,235 $1,719 (199) $1,036 (194) $1,525 39% 8% 47% Q3 FY23 140% (12)% (31)% 97% 25 August Guidance FY23E $2.5B -$2.6B ~(0.3)B $2.2B-$2.3B May Guidance FY23E ~$2.5B ~(0.3)B ~$2.2B EMERSON

View entire presentation